-
NuCana to Participate in Citi’s 14th Annual Biotech Conference
-
NuCana (NCNA) PT Lowered to $25 at Citi
-
NuCana to Participate in Citi's 2018 Global Healthcare Conference
-
NuCana to Participate in Citi's 2018 Global Healthcare Conference
-
NuCana to Participate in Citi’s 13th Annual Biotech Conference
-
NuCana to Participate in Citi’s 13th Annual Biotech Conference
-
Citi Starts NuCana (NCNA) at Buy
-
NuCana plc Announces Closing of Initial Public Offering of ADSs and Exercise of Underwriters’ Option to Purchase Additional ADSs
-
NuCana Plc (NCNA) Prices 6.67M ADS IPO at $15/Sh
-
NuCana plc Announces Pricing of Initial Public Offering

